Erin Lavik

Title: The Innovative Contributions of Erin Lavik

Introduction

Erin Lavik is a prominent inventor based in Branford, CT (US). She has made significant contributions to the field of biomedical engineering, particularly in the area of drug delivery systems. Her innovative work focuses on developing biodegradable polymeric microparticles for sustained intraocular delivery of drugs.

Latest Patents

Erin Lavik holds a patent for "Sustained intraocular delivery of drugs from biodegradable polymeric microparticles." This patent describes biodegradable polymeric microparticle compositions containing one or more active agents, especially those useful for treating or preventing diseases or disorders of the eye. A preferred embodiment of her invention includes microparticle compositions that manage elevated intraocular pressure (IOP) in the eye. The use of relatively hydrophilic, carboxylated polymeric materials such as PLGA allows for increased drug loading of water-soluble drugs like timolol maleate. The invention also explores the use of higher molecular weight polymers and the ratio of lactic acid (LA) to glycolic acid (GA) to provide a prolonged release of the drug over time.

Career Highlights

Throughout her career, Erin Lavik has worked with esteemed institutions such as Yale University and the University of Iowa Research Foundation. Her research has significantly advanced the understanding and application of drug delivery systems in ophthalmology.

Collaborations

Erin has collaborated with notable colleagues, including Young H Kwon and Markus Kuehn, to further her research and innovations in the field.

Conclusion

Erin Lavik's contributions to the field of drug delivery systems exemplify her dedication to improving medical treatments for eye disorders. Her innovative patent and collaborative efforts highlight her role as a leading inventor in biomedical engineering.